(Q39197051)

English

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus

scientific article published on 10 February 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

insulin resistance

1 reference

based on heuristic

inferred from title

Florian Kronenberg

19

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

object named as

Peter Willeit

5

0 references

Alexander R Moschen

object named as

Alexander R Moschen

7

0 references

object named as

Stefan Wirtz

12

0 references

Giovanna Muscogiuri

object named as

Giovanna Muscogiuri

8

0 references

object named as

Enzo Bonora

23

0 references

22

object named as

James B Meigs

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

26

object named as

Georg Schett

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Josef Penninger

21

object named as

Josef M Penninger

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

author name string

Stefan Kiechl

1

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Jürgen Wittmann

2

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Andrea Giaccari

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Michael Knoflach

4

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Aline Bozec

6

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Gian Pio Sorice

9

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Trayana Kireva

10

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Monika Summerer

11

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Julia Luther

13

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Dirk Mielenz

14

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Ulrike Billmeier

15

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Georg Egger

16

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Agnes Mayr

17

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Friedrich Oberhollenzer

18

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Michael Orthofer

20

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Herbert Tilg

24

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Johann Willeit

25

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

language of work or name

0 references

publication date

10 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

358-363

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Obesity, Inflammation, and Insulin Resistance

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Mechanisms of beta-cell death in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

IKK-beta links inflammation to obesity-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Osteoprotegerin as a predictor of coronary artery disease and cardiovascular mortality and morbidity

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Osteoprotegerin is a risk factor for progressive atherosclerosis and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Osteoprotegerin and soluble receptor activator of nuclear factor-kappaB ligand and risk for coronary events: a nested case-control approach in the prospective EPIC-Norfolk population study 1993-2003.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Soluble RANKL and risk of nontraumatic fracture

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

The RANKL/OPG system is activated in inflammatory bowel disease and relates to the state of bone loss

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Angiotensin II accelerates osteoporosis by activating osteoclasts

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Reactivation of silenced transgene expression in mouse liver by rapid, large-volume injection of isotonic solution.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Intravenous delivery of naked plasmid DNA for in vivo cytokine expression.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Depletion of liver Kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Defective hypothalamic autophagy directs the central pathogenesis of obesity via the IkappaB kinase beta (IKKbeta)/NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Inflammatory cause of metabolic syndrome via brain stress and NF-κB.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

NF-κB–inducing kinase (NIK) promotes hyperglycemia and glucose intolerance in obesity by augmenting glucagon action

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

An increased osteoprotegerin serum release characterizes the early onset of diabetes mellitus and may contribute to endothelial cell dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Endocrine regulation of energy metabolism by the skeleton

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Serum osteocalcin level is positively associated with insulin sensitivity and secretion in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Primary human bone marrow adipocytes support TNF-α-induced osteoclast differentiation and function through RANKL expression.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Stimulation of bone resorption and inhibition of bone formation in vitro by human tumour necrosis factors.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Navigating the choices for diabetes prevention

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Metformin stimulates osteoprotegerin and reduces RANKL expression in osteoblasts and ovariectomized rats

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Population-based incidence rates and risk factors for type 2 diabetes in white individuals: the Bruneck study

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Validation of the insulin sensitivity index (ISI(0,120)): comparison with other measures.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Relation of pooled logistic regression to time dependent Cox regression analysis: the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Lentivirus-delivered stable gene silencing by RNAi in primary cells

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Peripheral disruption of the Grb10 gene enhances insulin signaling and sensitivity in vivo

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Role of resistin in diet-induced hepatic insulin resistance

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic glucose clamp studies.

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

Toll-like Receptor 4 Polymorphisms and Atherogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNM.3084

21 January 2018

International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes: Diabetes Care 2009; 32(7): 1327-1334.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23396210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble receptor activator of nuclear factor-kappa B ligand and risk for cardiovascular disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/23396210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucose tolerance and insulin release, a mathematical approach I. Assay of the beta-cell response after oral glucose loading

1 reference

https://pubmed.ncbi.nlm.nih.gov/23396210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/23396210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts

1 reference

https://pubmed.ncbi.nlm.nih.gov/23396210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23396210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protective effect of metformin on periapical lesions in rats by decreasing the ratio of receptor activator of nuclear factor kappa B ligand/osteoprotegerin

1 reference

https://pubmed.ncbi.nlm.nih.gov/23396210

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/NM.3084

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39197051&oldid=2202668900"